Cancer Research Technology
Log in Register
Menu

Anti-AP2g [AP2g 6E4/4]

Invented by Helen Hurst
Invented at Queen Mary University of London

Info

Catalogue Number 151255
Applications IHC IP WB
Antigen/Gene or Protein Targets Activating Protein 2 (AP-2) gamma
Reactivity Human and Mouse
Relevance AP-2 is a family of developmentally regulated transcription factors which also play a role in breast cancer and melanoma. AP-2ß may be important in cardiac and kidney development. The AP-2 transcription factors form the OB2 complex that has been shown to up-regulate c-erb-B2 transcription.
Host Mouse
Immunogen Bacterially produced AP-2a/AP-2g fusion protein (c-terminal half of AP-2 gamma)
Positive Control MCF7 cells
Subclass IgG1
Molecular Weight (kDa) 50
Myeloma Used Sp2/0-Ag14
Recommended Growing Conditions E4 + 10% FCS
Strain Balb/c
Notes Antigen recovery will improve staining on paraffin sections.
Research Area Cancer, Cardiovascular, Epigenetics & Nuclear Signalling

References

There are 4 reference entries for this reagent.

View All References

References: 4 entries

Gee et al. 2009. J Pathol. 217(1):32-41. PMID: 18825690.

Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival.

Europe PMC ID: 18825690

Eloranta et al. 2002. J Biol Chem. 277(34):30798-804. PMID: 12072434.

Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo.

Europe PMC ID: 12072434


Add a reference

References: 4 entries

Gee et al. 2009. J Pathol. 217(1):32-41. PMID: 18825690.

Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival.

Eloranta et al. 2002. J Biol Chem. 277(34):30798-804. PMID: 12072434.

Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo.


Add a reference

Inventor Information